US Patent

US7935731 — Methods for concomitant administration of colchicine and macrolide antibiotics

Method of Use · Assigned to Mutual Pharmaceutical Co Inc · Expires 2028-12-03 · 3y remaining

Vulnerability score 80/100 Vulnerable — likely target for IPR or design-around

What this patent protects

Methods for safely administering colchicine with macrolide antibiotics, such as clarithromycin, are disclosed in this patent.

USPTO Abstract

Methods for concomitant administration of colchicine together with one or more macrolide antibiotics, e.g., clarithromycin, are disclosed. Such methods reduce the dangers commonly associated with such concomitant administration and provide additional benefits.

Drugs covered by this patent

Colcrys (COLCHICINE) · Scilex Pharms

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-1116`	—	Colcrys

Patent Metadata

Patent number: US7935731
Jurisdiction: US
Classification: Method of Use
Expires: 2028-12-03
Drug substance claim: No
Drug product claim: No
Assignee: Mutual Pharmaceutical Co Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.